Cargando…
Exploring the Role of ACE2 as a Connecting Link between COVID-19 and Parkinson’s Disease
Coronavirus disease 2019 (COVID-19) is frequently accompanied by neurological manifestations such as headache, delirium, and epileptic seizures, whereas ageusia and anosmia may appear before respiratory symptoms. Among the various neurological COVID-19-related comorbidities, Parkinson’s disease (PD)...
Autores principales: | Angelopoulou, Efthalia, Karlafti, Eleni, Georgakopoulou, Vasiliki E., Papalexis, Petros, Papageorgiou, Sokratis G., Tegos, Thomas, Savopoulos, Christos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961012/ https://www.ncbi.nlm.nih.gov/pubmed/36836893 http://dx.doi.org/10.3390/life13020536 |
Ejemplares similares
-
Genetic Insights into the Molecular Pathophysiology of Depression in Parkinson’s Disease
por: Angelopoulou, Efthalia, et al.
Publicado: (2023) -
Drug-Induced Liver Injury in Hospitalized Patients during SARS-CoV-2 Infection
por: Karlafti, Eleni, et al.
Publicado: (2022) -
Psychosis in Parkinson’s Disease: A Lesson from Genetics
por: Angelopoulou, Efthalia, et al.
Publicado: (2022) -
Pharmacological and Non-Pharmacological Treatments for Depression in Parkinson’s Disease: An Updated Review
por: Angelopoulou, Efthalia, et al.
Publicado: (2023) -
Cognitive Impairment in Parkinson’s Disease: An Updated Overview Focusing on Emerging Pharmaceutical Treatment Approaches
por: Degirmenci, Yildiz, et al.
Publicado: (2023)